Biosimilars : Design and Analysis of Follow-on Biologics.
As many biological products face losing their patents in the next decade, the pharmaceutical industry needs an abbreviated regulatory pathway for approval of biosimilar drug products, which are cost-effective, follow-on/subsequent versions of the innovator's biologic products. But scientific ch...
Saved in:
| Online Access: |
Full text (MCPHS users only) |
|---|---|
| Main Author: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Hoboken :
CRC Press,
2013
|
| Series: | Chapman & Hall/CRC biostatistics series.
|
| Subjects: | |
| Local Note: | ProQuest Ebook Central |
